While not everyone with IgG4-RD experiences headaches, the disease can impact areas that lead to persistent or severe headaches, such as: The meninges: These protective brain layers can thicken and become inflamed (hypertrophic pachymeningitis), resulting in ongoing, sometimes debilitating headaches
In research communities, these peptides are often discussed as complementary rather than directly competitive because: GHK-Cu is often chosen for collagen, skin, scar, and cosmetic tissue remodeling goals BPC-157 is often chosen for tendon, ligament, joint, muscle, and deeper recovery goals For that reason, many researchers discussing GHK-Cu vs BPC-157 eventually decide the better question is not which one is better, but which one better matches the tissue target? If you are building a broader research setup, you may also want to browse our research peptide collection for compatible inventory planning
Anti-amyloid monoclonal antibodies (lecanemab, donanemab) reliably clear amyloid with modest average clinical benefit
Retrieved 3 March 2022
